Log In
BCIQ
Print this Print this
 

ACT-901

  Manage Alerts
Collapse Summary General Information
Company Alpha Cancer Technologies Inc.
DescriptionCombination of paclitaxel and recombinant human alpha fetoprotein (AFP)
Molecular Target Alpha fetoprotein (AFP)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/19/2014

Undisclosed

Undisclosed

0

Get a free BioCentury trial today